 | • レポートコード：MRC2-11QY11837 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はエンジニアードT細胞のグローバル市場について調査・分析したレポートです。種類別（腫瘍浸潤リンパ球、T細胞受容体（TCR）、キメラ抗原受容体（CAR））市場規模、用途別（病院、がん研究センター、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別エンジニアードT細胞の競争状況、市場シェア ・世界のエンジニアードT細胞市場：種類別市場規模 2015年-2020年（腫瘍浸潤リンパ球、T細胞受容体（TCR）、キメラ抗原受容体（CAR）） ・世界のエンジニアードT細胞市場：種類別市場規模予測 2021年-2026年（腫瘍浸潤リンパ球、T細胞受容体（TCR）、キメラ抗原受容体（CAR）） ・世界のエンジニアードT細胞市場：用途別市場規模 2015年-2020年（病院、がん研究センター、クリニック） ・世界のエンジニアードT細胞市場：用途別市場規模予測 2021年-2026年（病院、がん研究センター、クリニック） ・北米のエンジニアードT細胞市場分析：米国、カナダ ・ヨーロッパのエンジニアードT細胞市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのエンジニアードT細胞市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のエンジニアードT細胞市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのエンジニアードT細胞市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Autolus Limited、Bellicum Pharmaceuticals、Cells Medica、Elli Lilly and Company、Gilead Sciences、Juno Therapeutics、Novartis、Oxford Biomedica、Pfizer、Precision Bioscience、Redmile Group、Seeking Alpha、Unum Therapeutics ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Engineered T Cells Market
The global Engineered T Cells market size is projected to reach US$ 336.1 million by 2026, from US$ 263.2 million in 2020, at a CAGR of 26.4%% during 2021-2026.
Global Engineered T Cells Scope and Market Size
Engineered T Cells market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Engineered T Cells market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Autolus Limited
Bellicum Pharmaceuticals
Cells Medica
Elli Lilly and Company
Gilead Sciences
Juno Therapeutics
Novartis
Oxford Biomedica
Pfizer
Precision Bioscience
Redmile Group
Seeking Alpha
Unum Therapeutics
Market segment by Type, the product can be split into
Tumor Infiltrating Lymphocytes
T Cell Receptor {TCR}
Chimeric Antigen Receptor (CAR)
Market segment by Application, split into
Hospitals
Cancer Research Centers
Clinics
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Engineered T Cells Revenue
1.4 Market by Type
1.4.1 Global Engineered T Cells Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Tumor Infiltrating Lymphocytes
1.4.3 T Cell Receptor {TCR}
1.4.4 Chimeric Antigen Receptor (CAR)
1.5 Market by Application
1.5.1 Global Engineered T Cells Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Cancer Research Centers
1.5.4 Clinics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Engineered T Cells Market Perspective (2015-2026)
2.2 Global Engineered T Cells Growth Trends by Regions
2.2.1 Engineered T Cells Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Engineered T Cells Historic Market Share by Regions (2015-2020)
2.2.3 Engineered T Cells Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Engineered T Cells Market Growth Strategy
2.3.6 Primary Interviews with Key Engineered T Cells Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Engineered T Cells Players by Market Size
3.1.1 Global Top Engineered T Cells Players by Revenue (2015-2020)
3.1.2 Global Engineered T Cells Revenue Market Share by Players (2015-2020)
3.1.3 Global Engineered T Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Engineered T Cells Market Concentration Ratio
3.2.1 Global Engineered T Cells Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Engineered T Cells Revenue in 2019
3.3 Engineered T Cells Key Players Head office and Area Served
3.4 Key Players Engineered T Cells Product Solution and Service
3.5 Date of Enter into Engineered T Cells Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Engineered T Cells Historic Market Size by Type (2015-2020)
4.2 Global Engineered T Cells Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Engineered T Cells Market Size by Application (2015-2020)
5.2 Global Engineered T Cells Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Engineered T Cells Market Size (2015-2020)
6.2 Engineered T Cells Key Players in North America (2019-2020)
6.3 North America Engineered T Cells Market Size by Type (2015-2020)
6.4 North America Engineered T Cells Market Size by Application (2015-2020)
7 Europe
7.1 Europe Engineered T Cells Market Size (2015-2020)
7.2 Engineered T Cells Key Players in Europe (2019-2020)
7.3 Europe Engineered T Cells Market Size by Type (2015-2020)
7.4 Europe Engineered T Cells Market Size by Application (2015-2020)
8 China
8.1 China Engineered T Cells Market Size (2015-2020)
8.2 Engineered T Cells Key Players in China (2019-2020)
8.3 China Engineered T Cells Market Size by Type (2015-2020)
8.4 China Engineered T Cells Market Size by Application (2015-2020)
9 Japan
9.1 Japan Engineered T Cells Market Size (2015-2020)
9.2 Engineered T Cells Key Players in Japan (2019-2020)
9.3 Japan Engineered T Cells Market Size by Type (2015-2020)
9.4 Japan Engineered T Cells Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Engineered T Cells Market Size (2015-2020)
10.2 Engineered T Cells Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Engineered T Cells Market Size by Type (2015-2020)
10.4 Southeast Asia Engineered T Cells Market Size by Application (2015-2020)
11 India
11.1 India Engineered T Cells Market Size (2015-2020)
11.2 Engineered T Cells Key Players in India (2019-2020)
11.3 India Engineered T Cells Market Size by Type (2015-2020)
11.4 India Engineered T Cells Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Engineered T Cells Market Size (2015-2020)
12.2 Engineered T Cells Key Players in Central & South America (2019-2020)
12.3 Central & South America Engineered T Cells Market Size by Type (2015-2020)
12.4 Central & South America Engineered T Cells Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Autolus Limited
13.1.1 Autolus Limited Company Details
13.1.2 Autolus Limited Business Overview
13.1.3 Autolus Limited Engineered T Cells Introduction
13.1.4 Autolus Limited Revenue in Engineered T Cells Business (2015-2020))
13.1.5 Autolus Limited Recent Development
13.2 Bellicum Pharmaceuticals
13.2.1 Bellicum Pharmaceuticals Company Details
13.2.2 Bellicum Pharmaceuticals Business Overview
13.2.3 Bellicum Pharmaceuticals Engineered T Cells Introduction
13.2.4 Bellicum Pharmaceuticals Revenue in Engineered T Cells Business (2015-2020)
13.2.5 Bellicum Pharmaceuticals Recent Development
13.3 Cells Medica
13.3.1 Cells Medica Company Details
13.3.2 Cells Medica Business Overview
13.3.3 Cells Medica Engineered T Cells Introduction
13.3.4 Cells Medica Revenue in Engineered T Cells Business (2015-2020)
13.3.5 Cells Medica Recent Development
13.4 Elli Lilly and Company
13.4.1 Elli Lilly and Company Company Details
13.4.2 Elli Lilly and Company Business Overview
13.4.3 Elli Lilly and Company Engineered T Cells Introduction
13.4.4 Elli Lilly and Company Revenue in Engineered T Cells Business (2015-2020)
13.4.5 Elli Lilly and Company Recent Development
13.5 Gilead Sciences
13.5.1 Gilead Sciences Company Details
13.5.2 Gilead Sciences Business Overview
13.5.3 Gilead Sciences Engineered T Cells Introduction
13.5.4 Gilead Sciences Revenue in Engineered T Cells Business (2015-2020)
13.5.5 Gilead Sciences Recent Development
13.6 Juno Therapeutics
13.6.1 Juno Therapeutics Company Details
13.6.2 Juno Therapeutics Business Overview
13.6.3 Juno Therapeutics Engineered T Cells Introduction
13.6.4 Juno Therapeutics Revenue in Engineered T Cells Business (2015-2020)
13.6.5 Juno Therapeutics Recent Development
13.7 Novartis
13.7.1 Novartis Company Details
13.7.2 Novartis Business Overview
13.7.3 Novartis Engineered T Cells Introduction
13.7.4 Novartis Revenue in Engineered T Cells Business (2015-2020)
13.7.5 Novartis Recent Development
13.8 Oxford Biomedica
13.8.1 Oxford Biomedica Company Details
13.8.2 Oxford Biomedica Business Overview
13.8.3 Oxford Biomedica Engineered T Cells Introduction
13.8.4 Oxford Biomedica Revenue in Engineered T Cells Business (2015-2020)
13.8.5 Oxford Biomedica Recent Development
13.9 Pfizer
13.9.1 Pfizer Company Details
13.9.2 Pfizer Business Overview
13.9.3 Pfizer Engineered T Cells Introduction
13.9.4 Pfizer Revenue in Engineered T Cells Business (2015-2020)
13.9.5 Pfizer Recent Development
13.10 Precision Bioscience
13.10.1 Precision Bioscience Company Details
13.10.2 Precision Bioscience Business Overview
13.10.3 Precision Bioscience Engineered T Cells Introduction
13.10.4 Precision Bioscience Revenue in Engineered T Cells Business (2015-2020)
13.10.5 Precision Bioscience Recent Development
13.11 Redmile Group
10.11.1 Redmile Group Company Details
10.11.2 Redmile Group Business Overview
10.11.3 Redmile Group Engineered T Cells Introduction
10.11.4 Redmile Group Revenue in Engineered T Cells Business (2015-2020)
10.11.5 Redmile Group Recent Development
13.12 Seeking Alpha
10.12.1 Seeking Alpha Company Details
10.12.2 Seeking Alpha Business Overview
10.12.3 Seeking Alpha Engineered T Cells Introduction
10.12.4 Seeking Alpha Revenue in Engineered T Cells Business (2015-2020)
10.12.5 Seeking Alpha Recent Development
13.13 Unum Therapeutics
10.13.1 Unum Therapeutics Company Details
10.13.2 Unum Therapeutics Business Overview
10.13.3 Unum Therapeutics Engineered T Cells Introduction
10.13.4 Unum Therapeutics Revenue in Engineered T Cells Business (2015-2020)
10.13.5 Unum Therapeutics Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Engineered T Cells Key Market Segments
Table 2. Key Players Covered: Ranking by Engineered T Cells Revenue
Table 3. Ranking of Global Top Engineered T Cells Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Engineered T Cells Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Tumor Infiltrating Lymphocytes
Table 6. Key Players of T Cell Receptor {TCR}
Table 7. Key Players of Chimeric Antigen Receptor (CAR)
Table 8. Global Engineered T Cells Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Engineered T Cells Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Engineered T Cells Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Engineered T Cells Market Share by Regions (2015-2020)
Table 12. Global Engineered T Cells Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Engineered T Cells Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Engineered T Cells Market Growth Strategy
Table 18. Main Points Interviewed from Key Engineered T Cells Players
Table 19. Global Engineered T Cells Revenue by Players (2015-2020) (Million US$)
Table 20. Global Engineered T Cells Market Share by Players (2015-2020)
Table 21. Global Top Engineered T Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Engineered T Cells as of 2019)
Table 22. Global Engineered T Cells by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Engineered T Cells Product Solution and Service
Table 25. Date of Enter into Engineered T Cells Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Engineered T Cells Market Size by Type (2015-2020) (Million US$)
Table 28. Global Engineered T Cells Market Size Share by Type (2015-2020)
Table 29. Global Engineered T Cells Revenue Market Share by Type (2021-2026)
Table 30. Global Engineered T Cells Market Size Share by Application (2015-2020)
Table 31. Global Engineered T Cells Market Size by Application (2015-2020) (Million US$)
Table 32. Global Engineered T Cells Market Size Share by Application (2021-2026)
Table 33. North America Key Players Engineered T Cells Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Engineered T Cells Market Share (2019-2020)
Table 35. North America Engineered T Cells Market Size by Type (2015-2020) (Million US$)
Table 36. North America Engineered T Cells Market Share by Type (2015-2020)
Table 37. North America Engineered T Cells Market Size by Application (2015-2020) (Million US$)
Table 38. North America Engineered T Cells Market Share by Application (2015-2020)
Table 39. Europe Key Players Engineered T Cells Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Engineered T Cells Market Share (2019-2020)
Table 41. Europe Engineered T Cells Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Engineered T Cells Market Share by Type (2015-2020)
Table 43. Europe Engineered T Cells Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Engineered T Cells Market Share by Application (2015-2020)
Table 45. China Key Players Engineered T Cells Revenue (2019-2020) (Million US$)
Table 46. China Key Players Engineered T Cells Market Share (2019-2020)
Table 47. China Engineered T Cells Market Size by Type (2015-2020) (Million US$)
Table 48. China Engineered T Cells Market Share by Type (2015-2020)
Table 49. China Engineered T Cells Market Size by Application (2015-2020) (Million US$)
Table 50. China Engineered T Cells Market Share by Application (2015-2020)
Table 51. Japan Key Players Engineered T Cells Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Engineered T Cells Market Share (2019-2020)
Table 53. Japan Engineered T Cells Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Engineered T Cells Market Share by Type (2015-2020)
Table 55. Japan Engineered T Cells Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Engineered T Cells Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Engineered T Cells Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Engineered T Cells Market Share (2019-2020)
Table 59. Southeast Asia Engineered T Cells Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Engineered T Cells Market Share by Type (2015-2020)
Table 61. Southeast Asia Engineered T Cells Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Engineered T Cells Market Share by Application (2015-2020)
Table 63. India Key Players Engineered T Cells Revenue (2019-2020) (Million US$)
Table 64. India Key Players Engineered T Cells Market Share (2019-2020)
Table 65. India Engineered T Cells Market Size by Type (2015-2020) (Million US$)
Table 66. India Engineered T Cells Market Share by Type (2015-2020)
Table 67. India Engineered T Cells Market Size by Application (2015-2020) (Million US$)
Table 68. India Engineered T Cells Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Engineered T Cells Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Engineered T Cells Market Share (2019-2020)
Table 71. Central & South America Engineered T Cells Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Engineered T Cells Market Share by Type (2015-2020)
Table 73. Central & South America Engineered T Cells Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Engineered T Cells Market Share by Application (2015-2020)
Table 75. Autolus Limited Company Details
Table 76. Autolus Limited Business Overview
Table 77. Autolus Limited Product
Table 78. Autolus Limited Revenue in Engineered T Cells Business (2015-2020) (Million US$)
Table 79. Autolus Limited Recent Development
Table 80. Bellicum Pharmaceuticals Company Details
Table 81. Bellicum Pharmaceuticals Business Overview
Table 82. Bellicum Pharmaceuticals Product
Table 83. Bellicum Pharmaceuticals Revenue in Engineered T Cells Business (2015-2020) (Million US$)
Table 84. Bellicum Pharmaceuticals Recent Development
Table 85. Cells Medica Company Details
Table 86. Cells Medica Business Overview
Table 87. Cells Medica Product
Table 88. Cells Medica Revenue in Engineered T Cells Business (2015-2020) (Million US$)
Table 89. Cells Medica Recent Development
Table 90. Elli Lilly and Company Company Details
Table 91. Elli Lilly and Company Business Overview
Table 92. Elli Lilly and Company Product
Table 93. Elli Lilly and Company Revenue in Engineered T Cells Business (2015-2020) (Million US$)
Table 94. Elli Lilly and Company Recent Development
Table 95. Gilead Sciences Company Details
Table 96. Gilead Sciences Business Overview
Table 97. Gilead Sciences Product
Table 98. Gilead Sciences Revenue in Engineered T Cells Business (2015-2020) (Million US$)
Table 99. Gilead Sciences Recent Development
Table 100. Juno Therapeutics Company Details
Table 101. Juno Therapeutics Business Overview
Table 102. Juno Therapeutics Product
Table 103. Juno Therapeutics Revenue in Engineered T Cells Business (2015-2020) (Million US$)
Table 104. Juno Therapeutics Recent Development
Table 105. Novartis Company Details
Table 106. Novartis Business Overview
Table 107. Novartis Product
Table 108. Novartis Revenue in Engineered T Cells Business (2015-2020) (Million US$)
Table 109. Novartis Recent Development
Table 110. Oxford Biomedica Business Overview
Table 111. Oxford Biomedica Product
Table 112. Oxford Biomedica Company Details
Table 113. Oxford Biomedica Revenue in Engineered T Cells Business (2015-2020) (Million US$)
Table 114. Oxford Biomedica Recent Development
Table 115. Pfizer Company Details
Table 116. Pfizer Business Overview
Table 117. Pfizer Product
Table 118. Pfizer Revenue in Engineered T Cells Business (2015-2020) (Million US$)
Table 119. Pfizer Recent Development
Table 120. Precision Bioscience Company Details
Table 121. Precision Bioscience Business Overview
Table 122. Precision Bioscience Product
Table 123. Precision Bioscience Revenue in Engineered T Cells Business (2015-2020) (Million US$)
Table 124. Precision Bioscience Recent Development
Table 125. Redmile Group Company Details
Table 126. Redmile Group Business Overview
Table 127. Redmile Group Product
Table 128. Redmile Group Revenue in Engineered T Cells Business (2015-2020) (Million US$)
Table 129. Redmile Group Recent Development
Table 130. Seeking Alpha Company Details
Table 131. Seeking Alpha Business Overview
Table 132. Seeking Alpha Product
Table 133. Seeking Alpha Revenue in Engineered T Cells Business (2015-2020) (Million US$)
Table 134. Seeking Alpha Recent Development
Table 135. Unum Therapeutics Company Details
Table 136. Unum Therapeutics Business Overview
Table 137. Unum Therapeutics Product
Table 138. Unum Therapeutics Revenue in Engineered T Cells Business (2015-2020) (Million US$)
Table 139. Unum Therapeutics Recent Development
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Engineered T Cells Market Share by Type: 2020 VS 2026
Figure 2. Tumor Infiltrating Lymphocytes Features
Figure 3. T Cell Receptor {TCR} Features
Figure 4. Chimeric Antigen Receptor (CAR) Features
Figure 5. Global Engineered T Cells Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Cancer Research Centers Case Studies
Figure 8. Clinics Case Studies
Figure 9. Engineered T Cells Report Years Considered
Figure 10. Global Engineered T Cells Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Engineered T Cells Market Share by Regions: 2020 VS 2026
Figure 12. Global Engineered T Cells Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Engineered T Cells Market Share by Players in 2019
Figure 15. Global Top Engineered T Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Engineered T Cells as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Engineered T Cells Revenue in 2019
Figure 17. North America Engineered T Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Engineered T Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Engineered T Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Engineered T Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Engineered T Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Engineered T Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Engineered T Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
循環腫瘍細胞（CTC）＆がん幹細胞の世界市場（～2026年） The tumor cells which have shed into lymphatic system and circulated over the body through blood circulation are called as circulating tumor cells. Circulating tumor cells may comprise seeds for metastasis. Stem cells are the type of cells that can differentiate into specialized cells and have the c…- 循環腫瘍細胞（CTC）予後技術の世界市場（～2026年） Circulating tumor cells (CTCs) are specialized rare cells, which have been shed from a primary solid tumor of the body and circulate in the vasculature system of the body, eventually causing metastasis. CTCs act as the seeds for successive development of additional metastatic tumors in distant organ…
- ヒト間葉系幹細胞（hMSC）の世界市場（～2026年） Human mesenchymal stem cells (hMSC) are multipotent stromal cells that can differentiate into a variety of cell types. Market Analysis and Insights: Global Human Mesenchymal Stem Cells (hMSC) Market The global Human Mesenchymal Stem Cells (hMSC) market size is projected to reach US$ XX million by 20…
- 臍帯血幹細胞の世界市場（～2026年） Market Analysis and Insights: Global Cord Blood Stem Cells Market The global Cord Blood Stem Cells market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cord Blood Stem Cells Scope and Market Size Cord Blood Stem Cells marke…
- 微生物燃料電池（MFC）の世界市場（～2026年） Microbial Fuel Cell (MFC) is a bio-electrochemical system that produces electric current by using bacteria. MFC is essentially a device that converts chemical energy into electrical energy by using bacteria or microorganisms. MFC has gained attention due to its capability to produce electricity from…